George Apostol

Mavoglurant in fragile X syndrome: Results of two randomized, double-blind, placebo-controlled trials

Elizabeth Berry‐Kravis, Vincent des Portes, Randi J. Hagerman et al. · Science Translational Medicine · 2016 · 264 citations

Life Sciences, Neuroscience, Psychiatry +5

Longitudinal association of body mass index with lung function: The CARDIA Study

Bharat Thyagarajan, David R. Jacobs, George Apostol et al. · Respiratory Research · 2008 · 175 citations · Full text

Health Professions, Health Sciences, Adolescent Health +13

Early Life Factors Contribute to the Decrease in Lung Function between Ages 18 and 40: The Coronary Artery Risk Development in Young Adults Study

George Apostol, David R. Jacobs, Albert W. Tsai et al. · American Journal of Respiratory and Critical Care Medicine · 2002 · 146 citations

Public Health, Health Behavior, Epidemiology +14

Mavoglurant in adolescents with fragile X syndrome: analysis of Clinical Global Impression-Improvement source data from a double-blind therapeutic study followed by an open-label, long-term extension study

Donald B. Bailey, Elizabeth Berry‐Kravis, Anne Wheeler et al. · Journal of Neurodevelopmental Disorders · 2015 · 100 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +16

A Randomized, Controlled, Phase 2 Study of Maralixibat in the Treatment of Itching Associated With Primary Biliary Cholangitis

Marlyn J. Mayo, Paul J. Pockros, David Jones et al. · Hepatology Communications · 2019 · 95 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +15